Shares of Series have moved -0.0% today, and are now trading at a price of $291.32. In contrast, the S&P 500 index saw a -0.0% change. Today's trading volume is 110,867 compared to the stock's average volume of 1,323,201.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. Based in Conshohocken, United States the company has 51,000 full time employees and a market cap of $56,480,538,624. Series currently offers its equity investors a dividend that yields 0.7% per year.
The company is now trading -12.59% away from its average analyst target price of $333.29 per share. The 14 analysts following the stock have set target prices ranging from $274.0 to $355.0, and on average give Series a rating of buy.
Over the last 52 weeks, COR stock has risen 24.2%, which amounts to a 6.8% difference compared to the S&P 500. The stock's 52 week high is $309.35 whereas its 52 week low is $218.65 per share. Based on Series's average net margin growth of inf% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 293,958,599 | 1,509,120 | 1 | 0.0 |
| 2023 | 262,173,411 | 1,745,293 | 1 | 0.0 |
| 2022 | 238,587,006 | 1,698,820 | 1 | 0.0 |
| 2021 | 213,988,843 | 1,539,932 | 1 | 150.0 |
| 2020 | 189,893,926 | -3,408,716 | -2 | -inf |
| 2019 | 179,589,121 | 855,365 | 0 |
